Cox model analysis of curative effect and prognostic factors of oral robot-assisted RPLN dissection for head and neck malignancies

doi:10.19439/j.sjos.2023.05.011

Abstract

Abstract: PURPOSE: To investigate the efficacy and prognostic factors of oral robot-assisted retropharyngeal lymph node (RPLN) dissection in the treatment of head and neck malignancies. METHODS: Sixty-eight patients with head and neck malignant tumors who were treated in our hospital from January 2017 to December 2019 and followed up until December 2022 were treated by oral robot-assisted RPLN dissection. The clinical remission rate, clinical control rate, operation time, intraoperative blood loss, length of hospital stay, and the survival rate and survival time at 1, 2 and 3 years of follow-up were compared. SPSS 22.0 software package was used for statistical analysis of the data. RESULTS: All 68 patients with head and neck tumors were successfully treated by oral robot-assisted RPLN resection, and no complications such as postpharyngeal incision massive bleeding, Horner syndrome, aspiration pneumonia were found in all patients. The follow-up was 3 years, the survival time was(31.15±4.93) months, the survival rate was 91.18%(62/68) at the first year, 85.29%(58/68) at the second year and 70.59% (48/68) at the third year. There was no significant difference in 3-year survival rate among different genders, ages, disease types, primary lesions, exocapsular lymph node invasion and peripheral nerve invasion (P>0.05). There were significant differences in the 3-year survival rate of different T stages, N stages, TNM stages, maximum diameter of invaded lymph nodes and vascular cancer thrombus(P<0.05). Cox proportional risk regression model analysis showed that stage T3 to 4, stage N2b to 3, stage Ⅳb TNM, maximum diameter of invaded lymph node >6 cm and vascular cancer thrombi were independent risk factors affecting the 3-year survival rate of head and neck cancer patients after surgery(P<0.05). CONCLUSIONS: Oral robotic assisted RPLN dissection has certain efficacy in the treatment of head and neck malignant tumors, but the survival rate of patients is affected by T stage, N stage, TNM stage, maximum diameter of invaded lymph nodes, vascular cancer thrombolus and other factors, which should be paid more attention in clinic.

Key words: Transoral robot, Postpharyngeal lymph node dissection, Head and neck malignancies, Cox model

CLC Number:

R739.8

DING Tai-ran, Julaiti·Tuerxun, YAO Zhi-tao, Maimaitituxun·Tuerdi. Cox model analysis of curative effect and prognostic factors of oral robot-assisted RPLN dissection for head and neck malignancies[J]. Shanghai Journal of Stomatology, 2023, 32(5): 508-512.

References

[1] Lin A, Chang JHC, Grover RS, et al.PTCOG head and neck subcommittee consensus guidelines on particle therapy for the management of head and neck tumors[J]. Int J Part Ther, 2021,8(1):84-94.
[2] 韩煜, 刘忠龙, 原光辉, 等. 头颈部恶性肿瘤放射治疗后下颌骨放射性骨坏死发病的影响因素研究[J]. 中华口腔医学杂志, 2021, 56(5): 421-427.
[3] 美国国立癌症综合信息网头颈肿瘤专家组. 头颈部恶性肿瘤诊断治疗指南[J].中华口腔医学杂志, 2006, 41(8): 453-455.
[4] 沈梦圆, 张雪莹, 赵姗, 等.头颈癌游离皮瓣患者术后谵妄危险因素及NLR的临床价值分析[J].中国口腔颌面外科杂志,2023,21(2):131-136.
[5] 张承宁, 李婷婷, 胡德馨, 等. 2010—2019年黔南州头颈部恶性肿瘤患者临床流行病学特征及流行学趋势分析[J]. 现代预防医学, 2021, 48(5): 952-956.
[6] Kobayashi K, Hisamatsu K, Suzui N, et al.A review of HPV-related head and neck cancer[J]. J Clin Med, 2018, 7(9): 241.
[7] 刘大响, 王令焕, 徐梅, 等. 头颈恶性肿瘤术后切口感染影响因素及CRP与sTREM-1和IL-6水平[J]. 中华医院感染学杂志, 2022, 32(3): 430-433.
[8] 侯振兴, 吕正华, 徐伟. 口咽和下咽鳞癌咽后淋巴结转移的临床特征及预后的Meta分析[J]. 中华耳鼻咽喉头颈外科杂志, 2022, 57(4): 467-473.
[9] 叶倩, 万鑫蕊, 宗井凤, 等. 咽后淋巴结转移鼻咽癌患者血浆EBV DNA和血清EB抗体与预后的关系[J]. 中国现代医学杂志, 2021, 31(14): 52-59.
[10] 王振霖, 刘俊其, 危维, 等. 内镜经口咽鼓管后下入路切除鼻咽癌咽后转移淋巴结的单中心回顾性研究[J]. 中华耳鼻咽喉头颈外科杂志, 2022, 57(11): 1328-1334.
[11] 谢萌, 张青青, 郭瑞昕, 等. 头颈部弥漫大B细胞淋巴瘤的临床特征分析[J].临床耳鼻咽喉头颈外科杂志, 2022, 36(1): 1-7.
[12] 刘宏飞, 黄志刚, 房居高, 等. 124例下咽癌患者甲状腺受侵及中央区淋巴结转移情况的回顾性研究[J]. 中华耳鼻咽喉头颈外科杂志, 2021, 56(9): 956-961.
[13] 章钰梅, 巩贯忠, 曹秀娟, 等. 基于CT/MRI/PET-CT进行鼻咽癌大体肿瘤区及淋巴结勾画的对照研究[J].中华放射医学与防护杂志, 2021, 41(9): 653-658.
[14] 刘坤, 顾湘, 陈南翔, 等. 头颈部恶性肿瘤患者肿瘤药物敏感性检测的临床意义[J]. 临床耳鼻咽喉头颈外科杂志, 2022, 36(3): 205-211.
[15] 李臻, 谢炳灿, 李鑫, 等. 经动脉化疗栓塞治疗头颈部恶性肿瘤疗效初探[J].临床放射学杂志, 2022, 41(9): 1761-1765.
[16] 杨钰华, 李红红, 黄佳林, 等. 头颈部肿瘤患者放疗后放射性脑干损伤的临床特征分析[J].中华放射医学与防护杂志, 2022, 42(3): 194-197.
[17] 张志丽, 郭彩霞. 头颈部恶性肿瘤术后急性肺栓塞临床特点及危险因素分析[J]. 首都医科大学学报, 2022, 43(5): 787-791.
[18] Abolfotouh S, Bäck L, Aro K, et al.Carotid interposition in patients with head and neck tumors: clinical experience of 13 cases reconstructed with a great saphenous vein autograft[J]. Acta Otolaryngol, 2022, 142(5): 419-424.
[19] 陈树伟, 张星, 黎建军, 等. 经口机器人辅助咽后淋巴结清扫术在头颈部恶性肿瘤中的应用[J]. 中华肿瘤杂志, 2022, 44(5): 446-449.
[20] 朱乔丹, 王立平, 徐栋. 超声引导下热消融治疗甲状腺乳头状癌术后颈部转移性淋巴结的疗效分析[J]. 介入放射学杂志, 2021, 30(4): 390-393.
[21] 钱薇, 朱国培, 嵇庆海, 等. 125例局部晚期头颈部鳞癌患者综合治疗的疗效和预后分析[J]. 中华肿瘤杂志, 2014, 36(3): 217-222.
[22] Park SS, Kim BC, Lee DE, et al. Comparison of endoscopic submucosal dissection and transanal endoscopic microsurgery for T1 rectal neuroendocrine tumors: a propensity score-matched study[J]. Gastrointest Endosc, 2021, 94(2): 408-415.e2.